04.02.2013 Views

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21) Application No.: 1187/MUM/2004 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 04/11/2004 (43) Publication Date: 09/06/2006<br />

(54) Title <strong>of</strong> <strong>the</strong> invention: IMMEDIATE RELEASE SULFONYLUREA TABLETS<br />

(51) International classification : A61K 31/155,<br />

31/64, 45/06<br />

(31) Priority Document No : NIL<br />

(32) Priority Date : NIL<br />

(33) Name <strong>of</strong> priority country : NIL<br />

(86) International Application No : NIL<br />

and Filing Date : NIL<br />

(87) International Publication No : NIL<br />

(61) Patent <strong>of</strong> addition to :<br />

Application No<br />

NIL<br />

(62)<br />

Filed on : N.A.<br />

Divisional to Application No : NIL<br />

Filed on : N.A.<br />

(71) Name <strong>of</strong> Applicant:<br />

GLENMARK PHARMACEUTICALS<br />

LIMITED<br />

Address <strong>of</strong> <strong>the</strong> Applicant:<br />

B/2, MAHALAXMI CHAMBERS, 22,<br />

BHULABHAI DESAI ROAD, POST<br />

BOX NO.26511, MUMBAI-400<br />

026,INDIA.<br />

(72) Name <strong>of</strong> <strong>the</strong> Inventor:<br />

1. MUTHAIYYAN ESAKKI<br />

KANNAN<br />

2. PREETHI BHUJANGA RAO<br />

3. ANANDI KRISHNAN<br />

Filed U/S 5(2) before The <strong>Patents</strong><br />

(Amendment) Act, 2005: YES<br />

(57) Abstract: A pharmaceutical composition comprising (a) a pharmaceutically effective amount <strong>of</strong> a<br />

sulfonylurea, (b) a dissolution enhancing effective amount <strong>of</strong> a homopolymer or copolymer <strong>of</strong> a vinyl pyrrolidone<br />

and (c) one or more pharmaceutically acceptable carrier materials, <strong>the</strong> composition being in a form <strong>of</strong> a unit<br />

dosage tablet and being an immediate release composition wherein at least about 50% <strong>of</strong> <strong>the</strong> sulfonylurea is<br />

dissolved in vitro within about 5 minutes in a 900 ml phosphate buffer solution <strong>of</strong> pH <strong>of</strong> 7.5 at 37ºC<br />

Drawing Sheets: NIL<br />

Total Pages: 22.<br />

Fig. Nil<br />

The Patent Office Journal 09/06/2006 10876

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!